Hospital
Multicare Health System
Multicare Health System was paid $108.54M by Medicaid between Jan 2018 and Dec 2024, across 415 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 26% of everything it billed.
33Billing provider infoMULTICARE HEALTH SYSTEM
TACOMA, WA 98405
TACOMA, WA 98405
33aNPI1306952726assigned 08/21/2006
33bProvider typeChildren's Hospital
28Total paid$108.54M
24GClaims1,507,757
24DCodes billed415
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ROBERTSON, WILLIAM controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 209,004 | $16.25M | |
| 2019 | 218,454 | $17.53M | |
| 2020 | 194,546 | $13.94M | |
| 2021 | 212,244 | $14.07M | |
| 2022 | 229,571 | $16.15M | |
| 2023 | 231,091 | $15.60M | |
| 2024incomplete | 212,847 | $15.00M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 26% | 212,578 | 188,121 | $28.35M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 94,378 | 89,754 | $15.56M |
| 96361 | Intravenous infusion, hydration; each additional hour | 4.8% | 12,300 | 10,012 | $5.26M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 4.5% | 2,896 | 2,862 | $4.93M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4.5% | 71,435 | 37,945 | $4.85M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.2% | 30,008 | 29,203 | $4.50M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.8% | 30,202 | 28,920 | $4.15M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 2.5% | 2,191 | 2,177 | $2.76M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.3% | 23,659 | 22,543 | $2.51M |
| 44970 | 2.2% | 623 | 612 | $2.43M | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.9% | 47,698 | 25,155 | $2.08M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.7% | 2,825 | 2,807 | $1.84M |
403 more codes
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.3% | 6,988 | $1.44M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 7,540 | $1.27M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1.2% | 1,729 | $1.25M |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 3,267 | $1.06M |
| 42830 | <1% | 597 | $989K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 9,126 | $988K |
| 92587 | <1% | 5,646 | $900K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 2,083 | $880K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 3,281 | $858K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 7,584 | $849K |
| 29085 | <1% | 2,185 | $724K | |
| 29065 | <1% | 2,163 | $719K | |
| 54161 | <1% | 515 | $701K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 452 | $642K |
| 97803 | <1% | 19,929 | $600K | |
| 76770 | <1% | 4,039 | $592K | |
| 12011 | <1% | 2,276 | $591K | |
| 95782 | <1% | 695 | $532K | |
| 95819 | <1% | 2,147 | $508K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 1,388 | $506K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,689 | $458K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 1,034 | $453K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 10,683 | $424K |
| 90378 | <1% | 1,302 | $418K | |
| 96415 | <1% | 917 | $416K | |
| 29075 | <1% | 1,189 | $393K | |
| 92579 | <1% | 4,967 | $388K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 8,269 | $382K |
| 12001 | <1% | 1,390 | $366K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 7,277 | $339K |
| G0378 | Hospital observation service, per hour | <1% | 9,529 | $309K |
| 92567 | <1% | 13,400 | $307K | |
| 97802 | <1% | 6,230 | $269K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,723 | $251K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 2,362 | $232K |
| 76937 | <1% | 2,467 | $232K | |
| 80053 | Comprehensive metabolic panel | <1% | 33,529 | $218K |
| 95715 | <1% | 480 | $208K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,490 | $194K |
| 95700 | <1% | 1,263 | $190K | |
| 96450 | <1% | 459 | $175K | |
| 20680 | <1% | 123 | $170K | |
| 92555 | <1% | 4,467 | $169K | |
| 54300 | <1% | 96 | $169K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 325 | $163K |
| 29425 | <1% | 394 | $139K | |
| 64643 | <1% | 519 | $139K | |
| 43762 | <1% | 595 | $132K | |
| 92552 | <1% | 1,798 | $129K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 2,945 | $129K |
| 76536 | <1% | 1,070 | $128K | |
| 24640 | <1% | 247 | $125K | |
| 76885 | <1% | 955 | $120K | |
| 76870 | <1% | 921 | $112K | |
| 42821 | <1% | 64 | $109K | |
| 92585 | <1% | 384 | $102K | |
| 54640 | <1% | 69 | $100K | |
| 43760 | <1% | 348 | $98K | |
| 49452 | <1% | 155 | $95K | |
| 64642 | <1% | 571 | $93K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 600 | $91K |
| 74230 | <1% | 777 | $91K | |
| L2275 | Addition to lower extremity, varus/valgus correction, plastic modification, padded/lined | <1% | 730 | $91K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 9,104 | $86K |
| 17250 | <1% | 214 | $81K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13,994 | $81K |
| 74018 | <1% | 10,745 | $75K | |
| 96367 | <1% | 702 | $73K | |
| 51600 | <1% | 217 | $71K | |
| 92553 | <1% | 960 | $71K | |
| 76942 | <1% | 511 | $68K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 470 | $68K |
| 95812 | <1% | 154 | $66K | |
| J1950 | Injection, leuprolide acetate (for depot suspension), per 3.75 mg | <1% | 88 | $65K |
| 69210 | <1% | 1,542 | $64K | |
| 10060 | <1% | 209 | $61K | |
| 25605 | <1% | 103 | $59K | |
| 24538 | <1% | 15 | $58K | |
| 97542 | <1% | 1,058 | $55K | |
| 92582 | <1% | 3,315 | $54K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 1,114 | $50K |
| 97166 | <1% | 913 | $48K | |
| 95813 | <1% | 107 | $47K | |
| 92526 | <1% | 996 | $46K | |
| 92630 | <1% | 231 | $46K | |
| 92652 | <1% | 638 | $46K | |
| 29105 | <1% | 227 | $44K | |
| 87631 | <1% | 1,687 | $43K | |
| 87040 | <1% | 4,305 | $42K | |
| 97162 | <1% | 874 | $42K | |
| 82784 | <1% | 4,620 | $42K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,299 | $39K |
| 92523 | <1% | 339 | $39K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 103 | $38K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,325 | $38K |
| 74455 | <1% | 217 | $38K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 29,696 | $38K |
| 95951 | <1% | 93 | $37K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 86 | $36K |
| 87505 | <1% | 591 | $36K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 44,072 | $35K |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | <1% | 14 | $35K |
| 73630 | <1% | 3,547 | $34K | |
| 36430 | <1% | 151 | $33K | |
| Q3014 | Telehealth originating site facility fee | <1% | 1,181 | $32K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 61 | $30K |
| L2840 | Addition to lower extremity orthosis, tibial length sock, fracture or equal, each | <1% | 1,047 | $30K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,393 | $29K |
| 99153 | Mod sedat endo service >5yrs | <1% | 7,664 | $29K |
| 67311 | <1% | 12 | $27K | |
| 29405 | <1% | 80 | $26K | |
| 80061 | Lipid panel | <1% | 3,086 | $24K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 533 | $23K |
| 81229 | <1% | 69 | $23K | |
| 73610 | <1% | 4,070 | $21K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 6,964 | $21K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,437 | $21K |
| 99151 | <1% | 4,083 | $20K | |
| 72082 | <1% | 1,850 | $20K | |
| 80050 | General health panel | <1% | 2,414 | $20K |
| 36592 | <1% | 19,781 | $19K | |
| 92511 | <1% | 51 | $19K | |
| D2390 | <1% | 27 | $19K | |
| 95816 | <1% | 77 | $17K | |
| 64640 | <1% | 31 | $16K | |
| 73502 | <1% | 2,583 | $15K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,608 | $15K |
| 99152 | <1% | 6,810 | $15K | |
| 73090 | <1% | 5,321 | $15K | |
| 73590 | <1% | 3,360 | $14K | |
| 82728 | <1% | 7,004 | $14K | |
| 73070 | <1% | 4,805 | $14K | |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 42 | $14K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 9,883 | $14K |
| 84145 | <1% | 1,778 | $13K | |
| 92611 | <1% | 707 | $13K | |
| 73110 | <1% | 3,465 | $13K | |
| 92557 | <1% | 173 | $13K | |
| 73560 | <1% | 2,339 | $13K | |
| 92610 | <1% | 264 | $13K | |
| 92558 | <1% | 178 | $12K | |
| 83020 | <1% | 834 | $12K | |
| 31575 | <1% | 37 | $11K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,355 | $11K |
| 80143 | <1% | 2,007 | $11K | |
| 73130 | <1% | 2,962 | $11K | |
| 12002 | <1% | 42 | $11K | |
| 76882 | <1% | 102 | $10K | |
| 94010 | <1% | 5,691 | $10K | |
| 73140 | <1% | 2,299 | $10K | |
| 92504 | <1% | 187 | $10K | |
| 96138 | <1% | 23 | $10K | |
| 84305 | <1% | 500 | $10K | |
| 86376 | <1% | 641 | $10K | |
| 84439 | <1% | 4,407 | $10K | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 159 | $9K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,611 | $9K |
| 86140 | <1% | 14,955 | $9K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 5,590 | $8K |
| 77072 | <1% | 877 | $8K | |
| 73552 | <1% | 1,521 | $8K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 260 | $8K |
| 84403 | <1% | 538 | $7K | |
| 83002 | <1% | 623 | $7K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 26 | $7K |
| 83655 | <1% | 577 | $7K | |
| 73100 | <1% | 1,867 | $7K | |
| J0475 | Injection, baclofen, 10 mg | <1% | 13 | $7K |
| 72081 | <1% | 739 | $6K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 116 | $6K |
| 83735 | <1% | 10,056 | $6K | |
| 16020 | <1% | 89 | $6K | |
| 74019 | <1% | 2,784 | $6K | |
| 87632 | <1% | 259 | $6K | |
| 83550 | <1% | 4,924 | $6K | |
| 80179 | <1% | 1,928 | $5K | |
| 73000 | <1% | 1,423 | $5K | |
| 81001 | <1% | 16,968 | $5K | |
| 25600 | <1% | 15 | $5K | |
| 86923 | <1% | 245 | $5K | |
| 29345 | <1% | 13 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 9,359 | $5K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 1,273 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 8,001 | $5K |
| 86665 | <1% | 970 | $5K | |
| 70486 | <1% | 66 | $5K | |
| 84484 | <1% | 781 | $5K | |
| 83540 | <1% | 5,113 | $4K | |
| J9250 | Methotrexate sodium, 5 mg | <1% | 405 | $4K |
| 85652 | <1% | 8,194 | $4K | |
| 70491 | <1% | 12 | $4K | |
| 36591 | <1% | 4,103 | $4K | |
| 77073 | <1% | 624 | $4K | |
| 86364 | <1% | 2,113 | $4K | |
| 83880 | <1% | 300 | $3K | |
| 86738 | <1% | 257 | $3K | |
| C1769 | Guide wire | <1% | 1,087 | $3K |
| 82248 | <1% | 8,930 | $3K | |
| L2820 | Addition to lower extremity orthosis, soft interface for molded plastic, below knee section | <1% | 45 | $3K |
| 76010 | <1% | 941 | $3K | |
| 73562 | <1% | 486 | $3K | |
| 87070 | <1% | 7,161 | $3K | |
| 29125 | <1% | 24 | $3K | |
| 74240 | <1% | 24 | $3K | |
| 86800 | <1% | 126 | $3K | |
| 82570 | <1% | 2,231 | $3K | |
| 97161 | <1% | 55 | $3K | |
| 83690 | <1% | 7,112 | $3K | |
| 87486 | <1% | 123 | $3K | |
| 85027 | <1% | 1,944 | $3K | |
| 82962 | <1% | 3,772 | $3K | |
| 81003 | <1% | 11,967 | $3K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 2,056 | $3K |
| 83615 | <1% | 8,408 | $3K | |
| 94664 | <1% | 1,663 | $3K | |
| 83001 | <1% | 338 | $2K | |
| 73521 | <1% | 220 | $2K | |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | <1% | 18 | $2K |
| 70360 | <1% | 796 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,428 | $2K |
| 80177 | <1% | 212 | $2K | |
| 0225U | <1% | 14,319 | $2K | |
| 87400 | <1% | 151 | $2K | |
| 84100 | <1% | 9,265 | $2K | |
| 80069 | <1% | 619 | $2K | |
| 83605 | <1% | 230 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 22,553 | $2K |
| 83516 | <1% | 2,681 | $2K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 74 | $2K |
| 84550 | <1% | 8,721 | $2K | |
| 36416 | <1% | 7,473 | $2K | |
| 62370 | <1% | 13 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 321 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,444 | $2K |
| A4649 | Surgical supply; miscellaneous | <1% | 2,459 | $2K |
| 86003 | <1% | 451 | $2K | |
| 76857 | <1% | 24 | $2K | |
| 85610 | <1% | 3,277 | $2K | |
| 83520 | <1% | 1,785 | $2K | |
| 73030 | <1% | 344 | $2K | |
| 87186 | <1% | 3,752 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 167 | $2K |
| 86480 | <1% | 253 | $2K | |
| 80076 | <1% | 318 | $2K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 7,277 | $2K |
| 76800 | <1% | 12 | $2K | |
| 91065 | <1% | 94 | $2K | |
| 96409 | <1% | 1,434 | $2K | |
| 81025 | <1% | 7,744 | $2K | |
| 73080 | <1% | 515 | $2K | |
| 72170 | <1% | 447 | $1K | |
| 87581 | <1% | 123 | $1K | |
| 0450 | Emergency room services | <1% | 31 | $1K |
| 97150 | Therapeutic procedure(s), group (2 or more individuals) | <1% | 168 | $1K |
| 85045 | <1% | 3,465 | $1K | |
| L3995 | Addition to upper extremity orthosis, sock, fracture or equal, each | <1% | 73 | $1K |
| 82785 | <1% | 135 | $1K | |
| 86235 | <1% | 185 | $1K | |
| 82670 | <1% | 47 | $1K | |
| 88304 | <1% | 1,941 | $1K | |
| 96376 | <1% | 2,679 | $1K | |
| 72040 | <1% | 145 | $1K | |
| 82550 | <1% | 1,327 | $1K | |
| 86850 | <1% | 2,011 | $1K | |
| 77076 | <1% | 64 | $1K | |
| 82607 | <1% | 432 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 13,068 | $1K |
| 85730 | <1% | 2,813 | $1K | |
| 82977 | <1% | 1,479 | $971.93 | |
| 87205 | <1% | 3,886 | $965.54 | |
| 86900 | <1% | 2,227 | $912.04 | |
| 87077 | <1% | 2,644 | $881.96 | |
| 82330 | <1% | 928 | $868.30 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 21,868 | $832.00 |
| 82077 | <1% | 1,951 | $813.43 | |
| 86256 | <1% | 102 | $806.90 | |
| 73060 | <1% | 375 | $770.85 | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 451 | $760.21 |
| 97165 | <1% | 14 | $732.06 | |
| B4087 | Gastrostomy/jejunostomy tube, standard, any material, any type, each | <1% | 784 | $719.84 |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 13 | $644.84 |
| 84703 | <1% | 1,861 | $610.75 | |
| 86901 | <1% | 2,232 | $599.76 | |
| 81243 | <1% | 15 | $592.06 | |
| 72100 | <1% | 108 | $573.55 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 8,260 | $551.02 |
| 83013 | <1% | 43 | $540.06 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 17,272 | $526.86 |
| 86341 | <1% | 42 | $522.37 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,798 | $521.01 |
| 88108 | <1% | 561 | $514.29 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,167 | $510.88 |
| 82247 | <1% | 288 | $510.01 | |
| 83970 | <1% | 42 | $499.13 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $494.97 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 17,900 | $493.35 |
| 83498 | <1% | 27 | $491.56 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 5,568 | $473.80 |
| 73660 | <1% | 56 | $464.09 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 17,443 | $447.36 |
| 97750 | <1% | 15 | $433.62 | |
| 86039 | <1% | 313 | $430.02 | |
| 85240 | <1% | 162 | $420.66 | |
| 82043 | <1% | 1,045 | $395.09 | |
| 82681 | <1% | 110 | $388.40 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 10,973 | $382.64 |
| 94644 | <1% | 585 | $375.76 | |
| 85245 | <1% | 122 | $367.03 | |
| D1351 | Sealant - per tooth | <1% | 17 | $352.92 |
| 83021 | <1% | 608 | $347.21 | |
| 90686 | <1% | 193 | $344.76 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 906 | $334.75 |
| 82746 | <1% | 211 | $317.58 | |
| 84156 | <1% | 394 | $298.29 | |
| D1120 | Dental cleaning, child | <1% | 473 | $296.55 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 2,457 | $283.20 |
| 82533 | <1% | 59 | $278.90 | |
| 36000 | <1% | 15 | $243.13 | |
| 83014 | <1% | 43 | $236.48 | |
| V5266 | Battery for use in hearing device | <1% | 50 | $234.18 |
| 82150 | <1% | 495 | $216.31 | |
| 85246 | <1% | 126 | $199.62 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,143 | $191.96 |
| D0220 | Intraoral - periapical first radiographic image | <1% | 311 | $174.74 |
| 89051 | <1% | 1,279 | $168.88 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 6,420 | $165.50 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,121 | $153.07 |
| 85384 | <1% | 108 | $149.26 | |
| 85379 | <1% | 28 | $147.62 | |
| 86481 | <1% | 12 | $144.80 | |
| 88342 | <1% | 214 | $133.28 | |
| 83993 | <1% | 25 | $130.02 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 39 | $120.66 |
| J9370 | Vincristine sulfate, 1 mg | <1% | 1,858 | $120.21 |
| 95012 | <1% | 1,431 | $104.96 | |
| 82465 | <1% | 209 | $101.56 | |
| 86160 | <1% | 87 | $72.41 | |
| 81015 | <1% | 204 | $69.02 | |
| 85014 | <1% | 40 | $65.88 | |
| 86769 | <1% | 68 | $59.60 | |
| D0272 | Bitewings - two radiographic images | <1% | 317 | $56.39 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 2,125 | $54.31 |
| 86308 | <1% | 375 | $51.69 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 2,902 | $48.41 |
| 85007 | <1% | 170 | $43.09 | |
| 86706 | <1% | 40 | $39.48 | |
| 84132 | <1% | 52 | $38.17 | |
| 86803 | <1% | 14 | $34.40 | |
| 87529 | <1% | 54 | $27.44 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 407 | $27.12 |
| 87340 | <1% | 14 | $27.10 | |
| 87045 | <1% | 16 | $27.00 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 76 | $23.53 |
| 82270 | <1% | 17 | $22.13 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 14 | $20.26 |
| 87425 | <1% | 12 | $19.62 | |
| 87427 | <1% | 15 | $19.61 | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 1,100 | $17.49 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 1,354 | $16.45 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 1,169 | $16.14 |
| V5264 | Ear mold/insert, not disposable, any type | <1% | 560 | $15.56 |
| 86920 | <1% | 21 | $10.59 | |
| 87184 | <1% | 19 | $10.23 | |
| Q4038 | Cast supplies, short leg cast, adult (11 years +), fiberglass | <1% | 43 | $10.19 |
| 83519 | <1% | 13 | $9.81 | |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | <1% | 40 | $9.65 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 299 | $5.54 |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | <1% | 216 | $5.25 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 213 | $4.53 |
| Q4012 | Cast supplies, short arm cast, pediatric (0-10 years), fiberglass | <1% | 140 | $4.06 |
| J1815 | Injection, insulin, per 5 units | <1% | 194 | $4.02 |
| 85651 | <1% | 12 | $3.97 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 104 | $3.79 |
| 82010 | <1% | 39 | $2.42 | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | <1% | 478 | $2.23 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 298 | $1.19 |
| J1836 | Injection, metronidazole, 10 mg | <1% | 124 | $0.72 |
| A4351 | Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each | <1% | 407 | $0.08 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 150 | $0.07 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 148 | $0.00 |
| D0230 | Intraoral - periapical each additional radiographic image | 0% | 160 | $0.00 |
| B4088 | Gastrostomy/jejunostomy tube, low-profile, any material, any type, each | 0% | 297 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 60 | $0.00 |
| 87430 | 0% | 52 | $0.00 | |
| 86141 | 0% | 14 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 16 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 212 | $0.00 |
| 96139 | 0% | 23 | $0.00 | |
| 92595 | 0% | 472 | $0.00 | |
| Q4014 | Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), fiberglass | 0% | 27 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 30 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 62 | $0.00 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 0% | 177 | $0.00 |
| J0694 | Injection, cefoxitin sodium, 1 gm | 0% | 320 | $0.00 |
| 84295 | 0% | 43 | $0.00 | |
| 92594 | 0% | 25 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 57 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 0% | 14 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 376 | $0.00 |
| 96401 | 0% | 54 | $0.00 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 13 | $0.00 |
| J9260 | Injection, methotrexate sodium, 50 mg | 0% | 64 | $0.00 |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROBERTSON, WILLIAM (CEO)
| Provider | Location | Paid |
|---|---|---|
| Multicare Health System | Tacoma, WA | $162.25M |
| Yakima Valley Memorial Hospital Association | Yakima, WA | $103.54M |
| Multicare Health System | Puyallup, WA | $77.99M |
| Multicare Health System | Tacoma, WA | $75.17M |
| Greater Lakes Mental Health Foundation INC | Lakewood, WA | $55.95M |
| Multicare Health System | Spokane, WA | $55.23M |
| Multicare Health System | Auburn, WA | $31.02M |
| Multicare Health System | Spokane Valley, WA | $24.75M |
| Multicare Health System | Covington, WA | $23.19M |
| Multicare Health System | Olympia, WA | $16.97M |
| Multicare Health System | Tacoma, WA | $11.14M |
| Multicare Health System | Auburn, WA | $7.42M |
| Multicare Health System | Tacoma, WA | $2.68M |
| Alliance for South Sound Health | Tacoma, WA | $2.46M |
| Capital Medical Center Physicians LLC | Olympia, WA | $1.75M |
| Multicare Health System | Tacoma, WA | $1.53M |
| Yakima Valley Memorial Hospital Association | Yakima, WA | $1.16M |
| Capital Medical Center Specialty Physicians, LLC | Olympia, WA | $987K |
| Yakima Urology at Memorial TR | Yakima, WA | $784K |
| Multicare Health System | Spokane, WA | $179K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.